Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS)

NCT: NCT06668246 · COMPLETED

NCT IDNCT06668246
StatusCOMPLETED
Start Date2022-10-01
Completion2023-04-30

Brief Summary

This study aimed to compare refractive measurements using Vision-S™ 700, an immersive and compact phoropter with a tunable-focus lens, and Vision-R™ 800, a phoropter with a tunable-focus lens without immersion, with cycloplegic refraction serving as the gold-standard. This a retrospective study aimed to enroll 41 children, aged 6 to 16 years, who underwent refractive assessments with Vision-S™ 700, Vision-R™ 800, and cycloplegic refraction. The primary objective involves a comparison of the spherical equivalent between both devices and compared to cycloplegic refraction. Secondary outcomes include the analysis of astigmatism components (J0° and J45°) and subgroup analyses in myopic and hyperopic children.

Frequently Asked Questions

What is Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS)?

Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS) is a clinical trial registered under NCT06668246. Current status: COMPLETED.

What is the status of NCT06668246?

The current status of NCT06668246 (Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS)) is: COMPLETED.

When did Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS) start?

Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS) started on 2022-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.